New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 24, 2022 - Dermavant Sciences announced the FDA approval of Vtama (tapinarof), for the topical treatment of plaque psoriasis in adults.
Download PDF
Return to publications
